Sectra offers radiology an easy way to improve gadolinium tracking

Linköping, Sweden – November 27, 2017 – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is globally introducing gadolinium tracking in its dose monitoring solution, Sectra DoseTrack. Gadolinium is a contrast agent commonly used to enhance images during MRI exams. By systematically registering gadolinium information, healthcare providers can reduce the risk of patients experiencing negative side effects of excessively high accumulated levels of gadolinium. Sectra is showcasing Sectra DoseTrack, including this functionality, during the RSNA global radiology show in Chicago.

“The use of contrast agents such as gadolinium is a very common way to enhance details of different organs during an MRI exam. However, for the sake of patient safety, it is crucial that radiology can easily track each gadolinium injection. By entering this information in Sectra DoseTrack, healthcare providers can ensure relevant information is available throughout the organization either from the EMR, from the dose monitoring solution or in Sectra PACS,” says Ian Judd, Product Manager for Sectra DoseTrack.

About Sectra DoseTrack
Sectra DoseTrack allows healthcare providers to monitor patient radiation exposure and ensure that the radiation doses are kept as low as reasonably achievable (ALARA) for increased patient safety. The cloud-based solution automatically collects, stores and monitors data from all connected modalities, saving valuable time and facilitating robust analysis for dose optimization. It can be configured using local and national dose reference levels (DLR) to allow healthcare organizations to ensure it is performing within expected thresholds.

Experience the solutions at RSNA 2017
Sectra’s solutions for radiology imaging, including Sectra DoseTrack, will be showcased at RSNA in booth #6113. Read more and book a meeting with Sectra at RSNA.

For further information, please contact:
Dr. Torbjörn Kronander, CEO and President Sectra AB, 46 (0) 705 23 52 27

Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, 46 (0)708 23 56 10


About Sectra 

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with subsidiaries in 15 countries, and operates through partners worldwide. Sales in the 2016/2017 fiscal year totaled SEK 1,141 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit www.sectra.com

In the medical market, Sectra develops and sells IT solutions for the management and communication of all types of medical images—primarily in radiology, mammography, pathology, cardiology and orthopaedics, as well as other departments where medical images are used. Sectra has a strategic focus on making cancer care more efficient. More than 1,700 hospitals, clinics and imaging centers worldwide use Sectra’s systems daily. This makes Sectra one of the world’s leading providers of IT solutions for managing medical images and patient information. The company commands a market-leading position in Sweden, Norway, the Netherlands and Portugal, holds a prominent position in the UK and is growing in the US. Sectra has delivered some of the largest installations of medical IT systems worldwide and its systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East.

Tags:

About Us

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2017/2018 fiscal year totaled SEK 1,267 million. The Sectra share (STO: SECT B) is quoted on the Nasdaq Stockholm exchange. For more information, visit www.sectra.com.

Subscribe

Media

Media

Quotes

The use of contrast agents such as gadolinium is a very common way to enhance details of different organs during an MRI exam. However, for the sake of patient safety, it is crucial that radiology can easily track each gadolinium injection. By entering this information in Sectra DoseTrack, healthcare providers can ensure relevant information is available throughout the organization either from the EMR, from the dose monitoring solution or in Sectra PACS
Ian Judd, Product Manager for Sectra DoseTrack